Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

USANDIZAGA

Showing results (141-150 of 165) with videos related to

Pageof 17
Sort By:
Metabolism: Clinical and Experimental|June 21, 2024
The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitisMaria Mercado-Gómez, Naroa Goikoetxea-Usandizaga, Annarein J C Kerbert, et al.
Molecular Metabolism|March 16, 2026
Hepatic HuR modulates glucose metabolism through the C/EBPβ/PCK1 pathwaySofia Lachiondo-Ortega, Irene González-Recio, Miren Bravo, et al.
Cancer Immunology Research|April 22, 2025
NEDDylation regulates CD8+ T cell metabolism and anti-tumor immunityBorja Jimenez-Lasheras, Paloma Velasco-Beltrán, Leire Egia-Mendikute, et al.
British Journal of Cancer|April 22, 2026
Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolismPietro Guerra, Gianmarco Villano, Claudia M Rejano-Gordillo, et al.
Communications Biology|August 17, 2022
The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytesMaria Mercado-Gómez, Endika Prieto-Fernández, Naroa Goikoetxea-Usandizaga, et al.
International Journal of Molecular Sciences|December 2, 2020
Multi-Omics Integration Highlights the Role of Ubiquitination in CCl<sub>4</sub>-Induced Liver FibrosisMaria Mercado-Gómez, Fernando Lopitz-Otsoa, Mikel Azkargorta, et al.
JHEP Reports : Innovation in Hepatology|May 17, 2021
Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injuryPaula Iruzubieta, Naroa Goikoetxea-Usandizaga, Lucía Barbier-Torres, et al.
Science Advances|October 22, 2025
Metabolic dysfunction-associated steatotic liver disease alters brain function and behavior: Insights from liver-targeted siRNA therapyTeresa Cardoso Delgado, Celia Martín-Cuevas, Ana C Sánchez Hidalgo, et al.
Antioxidants (Basel, Switzerland)|May 28, 2022
Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from AcetaminophenRubén Rodríguez-Agudo, Naroa Goikoetxea-Usandizaga, Marina Serrano-Maciá, et al.
Cell Metabolism|February 22, 2020
Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride AssemblyJorge Simon, Maitane Nuñez-García, Pablo Fernández-Tussy, et al.
Pageof 17

Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
Metabolism: Clinical and Experimental|June 21, 2024
The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitisMaria Mercado-Gómez, Naroa Goikoetxea-Usandizaga, Annarein J C Kerbert, et al.
Molecular Metabolism|March 16, 2026
Hepatic HuR modulates glucose metabolism through the C/EBPβ/PCK1 pathwaySofia Lachiondo-Ortega, Irene González-Recio, Miren Bravo, et al.
Cancer Immunology Research|April 22, 2025
NEDDylation regulates CD8+ T cell metabolism and anti-tumor immunityBorja Jimenez-Lasheras, Paloma Velasco-Beltrán, Leire Egia-Mendikute, et al.
British Journal of Cancer|April 22, 2026
Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolismPietro Guerra, Gianmarco Villano, Claudia M Rejano-Gordillo, et al.
Communications Biology|August 17, 2022
The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytesMaria Mercado-Gómez, Endika Prieto-Fernández, Naroa Goikoetxea-Usandizaga, et al.
International Journal of Molecular Sciences|December 2, 2020
Multi-Omics Integration Highlights the Role of Ubiquitination in CCl<sub>4</sub>-Induced Liver FibrosisMaria Mercado-Gómez, Fernando Lopitz-Otsoa, Mikel Azkargorta, et al.
JHEP Reports : Innovation in Hepatology|May 17, 2021
Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injuryPaula Iruzubieta, Naroa Goikoetxea-Usandizaga, Lucía Barbier-Torres, et al.
Science Advances|October 22, 2025
Metabolic dysfunction-associated steatotic liver disease alters brain function and behavior: Insights from liver-targeted siRNA therapyTeresa Cardoso Delgado, Celia Martín-Cuevas, Ana C Sánchez Hidalgo, et al.
Antioxidants (Basel, Switzerland)|May 28, 2022
Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from AcetaminophenRubén Rodríguez-Agudo, Naroa Goikoetxea-Usandizaga, Marina Serrano-Maciá, et al.
Cell Metabolism|February 22, 2020
Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride AssemblyJorge Simon, Maitane Nuñez-García, Pablo Fernández-Tussy, et al.
Pageof 17